Work

Soluble ST2 (sST2) Is a Novel Valuable Prognostic Marker Among Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Year: 2013

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v122.21.3095.3095

Authors: Angela Dispenzieri, Amy K. Saenger, Shaji K. Kumar, Morie A. Gertz, Martha Q Lacy, Francis Buadi, Suzanne R Hayman, Nelson Leung, Steven R Zeldenrust, Arleigh McCurdy, Robert Kyle, David Dingli, Prashant Kapoor, Yi Lin, Stephen J. Russell, Ronald S. Go, Allan S. Jaffe

Institution: Mayo Clinic

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980087177

FWCI: 0.403

Cites:

Cited by: 3

Related to: 10